- What is Newborn Screening?
- Is Newborn Screening testing required?
- Is Newborn Screening a new program?
- How is the screening performed?
- What are the limitations?
- What if my baby needs a retest? Does that mean that my baby has the disorder?
- How will I learn my baby’s results?
- Can I say NO to the test?
- How much does it cost me?
- How can I get more information?
- What disorders are included on the newborn screening panel?
What is Newborn Screening?
Newborn screening is a comprehensive program that includes testing, follow-up of results, and if necessary, examination and treatment by a qualified specialist. Early detection and treatment of the disorders on the newborn screening panel can prevent life long disabilities, including mental retardation, developmental disabilities, and life threatening infections. Without treatment permanent disability, and even death, can occur.
Is Newborn Screening testing required?
All babies born in New Jersey are required by law to be tested for fifty-four (54) disorders within 48 hours of birth. One heel prick provides enough blood to test for all fifty-four disorders.

Is Newborn Screening a new program?
No. New Jersey began testing for Phenylketonuria (PKU), a metabolic disease, in 1964. Since that time, newborn screening has expanded to include detection for more than fifty disorders. Currently, all U.S. states mandate newborn testing for PKU, Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, Galactosemia, and Sickle Cell Anemia.

How is the screening performed?
All screening tests are performed on a tiny blood sample, obtained by pricking the heel of your baby. Samples are usually taken at the hospital before your baby is discharged home. The sample is allowed to air dry and is then submitted to the Newborn Screening Laboratory for testing. Any abnormal results are reported to the Newborn Screening and Genetic Services program for follow-up activities.

What are the limitations?
The tests performed are ‘screening’ tests and are different from diagnostic tests. The screen cannot detect all inborn errors of metabolism. The test may fail to identify some babies with these disorders, and some babies who test positive may not actually have the disorder. Sometimes babies who are born prematurely, who are underweight at birth, or who may have received a blood transfusion can test positive, but not have the disorder. Your baby’s doctor may want to repeat the newborn screening test or do other testing to check the results.

What if my baby needs a retest? Does that mean that my baby has the disorder?
Not necessarily. There are several reasons why your baby may need to be retested. Some of those reasons may include:
- Your baby was less than 24 hours old at the time the first blood sample was taken
- The blood sample was collected while the baby was receiving special formula or was on medication
- The sample did not contain enough blood or the blood was not taken properly
- Your baby was premature or underweight
- The results were very close to normal and a retest is needed to rule out the disorder

How will I learn my baby’s results?
Make sure that your birth hospital and your baby’s doctor have your correct address and phone number. Your baby’s test results will be sent to your baby’s doctor and to the hospital where the sample was taken. You should ask your baby’s doctor for the test results when you bring the baby in for his/her first checkup. If your baby needs a retest you will be notified by your baby’s doctor or you will get a letter from the Newborn Screening Laboratory or the Newborn Screening Follow-up Program. If your baby does need a retest, get it done right away.

Can I say NO to the test?
An exception is made when parents object on the grounds that the tests are against their religious beliefs or practices. A signed statement to this effect must be recorded in the baby’s hospital record.

How much does it cost me?
There is no charge to the patient for the state newborn screening test.

How can I get more information?
For more information on Newborn Screening in New Jersey you can contact the Newborn Screening Follow-up Program at (609) 292-1582.
The following websites have information regarding newborn screening:
CENTERS FOR DISEASE CONTROL AND PREVENTION
www.cdc.gov
NATIONAL INSTITUTES OF HEALTH
www.nih.gov/health
MARCH OF DIMES
www.modimes.org
NATIONAL NEWBORN SCREENING AND GENETIC RESOURCECENTER
www.genes-r-us.uthscsa.edu
SAVE BABIES THROUGH SCREENING FOUNDATION
www.savebabies.org

What disorders are included on the newborn screening panel?
Disorder Name |
Abbreviation |
Fatty Acid Oxidation Disorders |
2,4-Dienoyl-CoA reductase deficiency |
DERED |
Carnitine palmitoyltransferase I deficiency |
CPT I |
Carnitine palmitoyltransferase II deficiency |
CPT II |
Carnitine/acylcarnitine translocase deficiency |
CACT |
Carnitine uptake defect |
CUD |
Glutaric acidemia type II |
GA II |
Long chain 3-Hydroxyacyl-CoA dehydrogenase deficiency |
LCHAD |
Long chain acyl-CoA dehydrogenase deficiency |
LCAD |
Medium/Short chain 3-Hydroxy acyl-CoA dehydrogenase deficiency |
M/SCHAD |
Medium chain acyl-CoA dehydrogenase deficiency |
MCAD |
Medium chain ketoacyl-CoA thiolase deficiency |
MCKAT |
Short chain acyl-CoA dehydrogenase deficiency |
SCAD |
Trifunctional protein deficiency |
TFP |
Very long chain acyl-CoA dehydrogenase deficiency |
VLCAD |
|
|
Organic Acidemia Disorders |
2-Methyl-3-hydroxybutyric aciduria |
2M3HBA |
2-Methylbutyrylglycinuria |
2MBG |
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency |
HMG |
3-Methylcrotonyl-CoA carboxylase deficiency |
3MCC |
3-Methylglutaconic aciduria |
3MGA |
beta-Ketothiolase deficiency |
BKT |
Glutaric acidemia type I |
GA I |
Isobutyrylglycinuria |
IBD |
Isovaleric acidemia |
IVA |
Malonic acidemia |
MAL |
Methylmalonic acidemia - Cobalamin A, B |
CBL A, B |
Methylmalonic acidemia - Cobalamin C, D |
CBL C, D |
Methylmalonic acidemia - Mutase |
MUT |
Multiple carboxylase deficiency |
MCD |
Propionic acidemia |
PROP |
|
|
Amino Acid & Urea Cycle Disorders |
Argininemia |
ARG |
Argininosuccinic acidemia |
ASA |
Hyperphenylalanemia (benign) |
H-PHE |
Biopterin cofactor defect of biosynthesis |
BIOPT-BIO |
Biopterin cofactor defect of regeneration |
BIOPT-REG |
Citrullinemia type I |
CIT I |
Citrullinemia type II |
CIT II |
Homocystinuria |
HCY |
Hypermethioninemia |
MET |
Maple syrup urine disease |
MSUD |
Phenylketonuria |
PKU |
Tyrosinemia type I |
TYR I |
Tyrosinemia type II |
TYR II |
Tyrosinemia type III |
TYR III |
|
Endocrine Disorders |
|
Congential Adrenal Hyperplasia |
CAH |
Congenital Hypothyroidism |
CH |
|
|
Metabolic Disorders |
|
Biotinidase deficiency |
BIOT |
Classical galactosemia |
GALT |
Galactoepimerase deficiency |
GALE |
Galactokinase deficiency |
GALK |
|
|
Other Disorders |
|
Cystic fibrosis CF |
CF |
Hemoglobin S/Beta-thalassemia S/βThal |
S/bThal |
Hemoglobin S/C disease S/C |
S/C |
Other Hemoglobinopathies Var Hb |
Var Hb |
Sickle cell anemia S/S |
S/S |
|
You can get more information on these 54 disorders by clicking here:
http://www.acmg.net/resources/policies/ACT/condition-analyte-links.htm
or here:
http://www.savebabies.org/professionals/diseasedescriptions.html
|
|